TIC10/ONC201 in combination with ceralasertib exhibits potent synergy in high grade serous ovarian cancer cells

被引：0
|
作者：
Ghandali, Maryam
Selvi, Kadir Mert
Huntington, Kelsey E.
George, Andrew
Ochsner, Anna
Carneiro, Benedito A.
Dizon, Donn S.
El-Deiry, Wafik S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5512
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TRAIL-inducing imipridone ONC201/TIC10 demonstrates anti-neoplastic effects in colonic adenoma-derived organoids
    Lannigan, Alexis J.
    Chan, Jasper
    Schwermann, Maximilian
    Zhou, Lanlan
    Prabhu, Varun V.
    Dame, Michael
    Brenner, Dean
    El-Deiry, Wafik S.
    Raufi, Alexander G.
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Screen of Small Molecule ONC201/TIC10 Identifies Single Agent Activity and Combinatorial Efficacy with Bortezomib, Rituximab or Dexamethasone in Killing of Acute Lymphoblastic Leukemia Cells
    Wagner, Jessica M.
    Prabhu, Varun Vijay
    Kline, Leah L.
    Lulla, Amriti R.
    Hernandez-Borrero, Liz J.
    Pu, Jeffrey J.
    Dicker, David T.
    Barth, Brian M.
    Claxton, David F.
    Allen, Joshua E.
    El-Deiry, Wafik S.
    BLOOD, 2014, 124 (21)
  • [33] ONC201 shows efficacy in BRCA-deficient cancer cells and synergy with PARP inhibitors in glioblastoma, breast, prostate, and ovarian cancers
    Baumeister, Marie D.
    Kucukkase, Ozan C.
    Prabhu, Varun V.
    Dicker, David T.
    Allen, Josh E.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2017, 77
  • [34] PARP inhibitor rucaparib in combination with imipridones ONC201 or ONC212 demonstrates preclinical synergy against BRCA1/2-deficient breast, ovarian, and prostate cancer cells
    Ghandali, Maryam
    Huntington, Kelsey E.
    Srinivasan, Praveen
    Dizon, Don S.
    Graff, Stephanie L.
    Carneiro, Benedito A.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner
    Prabhu, Varun V.
    Allen, Joshua E.
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2015, 75 (07) : 1423 - 1432
  • [36] Small molecule ONC201/TIC10 inhibits HIV-1 replication in reservoir cell types in vitro and in mouse brains xenotransplanted with human macrophages
    Zhao, R. Z.
    Wu, B. W.
    Zheng, J. C. Z.
    Huang, Y. H.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S47 - S47
  • [37] Small Molecule ONC201/TIC10 Induces Caspase-Dependent Apoptosis in Acute Lymphoblastic Leukemia Cells Via Modulation of Bcl-2 and IAP Family Proteins
    Prabhu, Varun Vijay
    Lulla, Amriti R.
    Wagner, Jessica M.
    Hernandez-Borrero, Liz J.
    Talekar, Mala K.
    Kline, Christina L.
    Dicker, David T.
    Barth, Brian M.
    Pu, Jeffrey J.
    Claxton, David F.
    Allen, Joshua E.
    El-Deiry, Wafik S.
    BLOOD, 2014, 124 (21)
  • [38] Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway (Vol 14, 99, 2015)
    Allen, Joshua E.
    Krigsfeld, Gabriel
    Patel, Luv
    Mayes, Patrick A.
    Dicker, David T.
    Wu, Gen Sheng
    El-Deiry, Wafik S.
    MOLECULAR CANCER, 2024, 23 (01)
  • [39] Early integrated stress response induction of ATF4 is required for the anticancer effects of the dual Akt/ERK inhibitor and TRAIL pathway inducer ONC201/TIC10
    Kline, Christina Leah
    van den Heuvel, Pieter
    Allen, Joshua E.
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2015, 75
  • [40] The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
    de la Nava, Daniel
    Ausejo-Mauleon, Iker
    Laspidea, Virginia
    Gonzalez-Huarriz, Marisol
    Lacalle, Andrea
    Casares, Noelia
    Zalacain, Marta
    Marrodan, Lucia
    Garcia-Moure, Marc
    Ochoa, Maria C.
    Tallon-Cobos, Antonio Carlos
    Hernandez-Osuna, Reyes
    Marco-Sanz, Javier
    Dhandapani, Laasya
    Hervas-Corpion, Irati
    Becher, Oren J.
    Nazarian, Javad
    Mueller, Sabine
    Phoenix, Timothy N.
    van der Lugt, Jasper
    Hernaez, Mikel
    Guruceaga, Elizabeth
    Koschmann, Carl
    Venneti, Sriram
    Allen, Joshua E.
    Dun, Matthew D.
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Perez-Larraya, Jaime Gallego
    Patino-Garcia, Ana
    Labiano, Sara
    Alonso, Marta M.
    NEURO-ONCOLOGY, 2024, 26 (08) : 1509 - 1525
12345